Substance / Medication

Indomethacin sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

17 trials linked to this intervention

17
Total Trials
5
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Early versus Late Caffeine Therapy Administration in Preterm Neonates: An Updated Systematic Review and Meta-Analysis.
Karlinski Vizentin Vanessa, Madeira de Sá Pacheco Isabela, Fahel Vilas Bôas Azevêdo Thalita et al. · Neonatology · 2024
PMID: 37989113Meta-Analysis
The risk of myocardial infarction and heart failure in patients with gouty arthritis: A systematic review and meta-analysis.
Wu Qinglin, Fu Chuangong, Lu Zhifu · Int J Rheum Dis · 2023
PMID: 36537294Meta-Analysis
Effect of nanoparticles on gouty arthritis: a systematic review and meta-analysis.
Zhu Ruiting, Niu Yirou, Zhou Wei et al. · BMC Musculoskelet Disord · 2023
PMID: 36788552Meta-AnalysisFull text (PMC)
Role of NLRP3 in the pathogenesis and treatment of gout arthritis.
Liu Ya-Ru, Wang Jie-Quan, Li Jun · Front Immunol · 2023
PMID: 37051231Meta-AnalysisFull text (PMC)
Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review.
Schlesinger Naomi, Pillinger Michael H, Simon Lee S et al. · Arthritis Res Ther · 2023
PMID: 37491293Meta-AnalysisFull text (PMC)
Herbal medicine for external use in acute gouty arthritis: A PRISMA-compliant systematic review and meta-analysis.
Choi Su Hyeon, Song Ho-Sueb, Hwang Jihye · Medicine (Baltimore) · 2023
PMID: 37713880Meta-AnalysisFull text (PMC)
Effect of Formulation and Process Parameters on the Disproportionation of Indomethacin Sodium in Buffered Lyophilized Formulations.
Koranne Sampada, Thakral Seema, Suryanarayanan Raj · Pharm Res · 2018
PMID: 29305664Other
Root cause evaluation of particulates in the lyophilized indomethacin sodium trihydrate plug for parenteral administration.
Siddiqui Akhtar, Rahman Ziyaur, Khan Saeed R et al. · Int J Pharm · 2014
PMID: 25089509Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Indometacin sodium (substance)
SNOMED CT
783274005
UMLS CUI
C0982211

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

7
Conditions
2
Biomarkers
1
Specialists
0
Symptoms
17
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.